Ace the 2026 COMAT Psychiatry Challenge – Boost Your Brainpower Today!

The major treatment for Intermittent Explosive Disorder (IED) often involves the use of Selective Serotonin Reuptake Inhibitors (SSRIs). This is because SSRIs can help in managing the mood dysregulation and impulsivity that are characteristic of IED. Research has shown that these medications can reduce the frequency and intensity of explosive outbursts, providing a pharmacological approach to help stabilize mood and decrease irritability.

Cognitive-behavioral therapy (CBT) is also an effective treatment modality for IED, as it can help patients develop better coping strategies and improve emotional regulation; however, when considering the primary pharmacological treatment, SSRIs stand out. While there are various types of antidepressants, SSRIs specifically target serotonin pathways that are implicated in mood and behavior disorders, which is vital for the treatment of IED.

Electroconvulsive therapy (ECT) is typically reserved for severe cases of depression or other treatment-resistant disorders and is not a first-line treatment for IED. Antidepressants that only increase serotonin may not provide the same broad effects as SSRIs, which also modulate other neurotransmitter systems and have a more comprehensive impact on mood stability.